LENZ Therapeutics, Inc.·4

May 14, 5:29 PM ET

MCCOLLUM JAMES W 4

4 · LENZ Therapeutics, Inc. · Filed May 14, 2024

Insider Transaction Report

Form 4
Period: 2024-05-13
Transactions
  • Purchase

    Common Stock

    2024-05-13$15.99/sh+31,332$501,093525,565 total(indirect: By Trust)
Holdings
  • Common Stock

    95,034
Footnotes (1)
  • [F1]Represents the weighted average share price of an aggregate total of 31,332 shares purchased in the price range of $15.96 to $16.00 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    wk-form4_1715722170.xmlPrimary

    FORM 4